The EVERY Company: Funding, Investors & Team (Sep 2026)
The EVERY Company is the market leader in engineering, manufacturing and formulating animal-free, animal proteins as ingredients for the global food and beverage industry. Leveraging advanced fermentation to produce functional and nutritional proteins from microorganisms, the Company is reimagining the factory farm model that underpins industrial animal agriculture with a more sustainable, kinder, and healthier alternative. Clara Foods is on a mission to decouple the world's most powerful proteins from the animals that make them.
The EVERY Company has raised $57.0M across 2 funding rounds on record, the most recent a Series D of $55.0M announced in Nov 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
The EVERY Company Company Profile and Key Stats
Latest funding round on record: Nov 2025.
The EVERY Company Funding Rounds
The EVERY Company raised $2.0M in an undisclosed round announced in Dec 2024.
11 months later, a Series D of $55.0M was announced in Nov 2025.
The EVERY Company Founders and Leadership Team
Contact details for the The EVERY Company team: 1 of 1 has an email address on file.
Start 14-day free trial →The EVERY Company Funding Compared to Other Biotechnology Startups
The EVERY Company's latest round of $55.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like The EVERY Company in Biotechnology and South San Francisco
Companies Similar to The EVERY Company
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
The EVERY Company Funding FAQs
What does The EVERY Company do?
The EVERY Company is the market leader in engineering, manufacturing and formulating animal-free, animal proteins as ingredients for the global food and beverage industry. Leveraging advanced fermentation to produce functional and nutritional proteins from microorganisms, the Company is reimagining the factory farm model that underpins industrial animal agriculture with a more sustainable, kinder, and healthier alternative. Clara Foods is on a mission to decouple the world's most powerful proteins from the animals that make them.
How much funding has The EVERY Company raised?
The EVERY Company has raised $57.0M across 2 rounds on record. The most recent is a Series D of $55.0M announced in Nov 2025.
When did The EVERY Company last raise funding?
The EVERY Company's most recent funding round on record is a Series D of $55.0M, announced in Nov 2025.
Who founded The EVERY Company?
FundedIQ lists Arturo Elizondo (Founder) at The EVERY Company.
Where is The EVERY Company headquartered?
The EVERY Company is based in South San Francisco, California, United States.
How many employees does The EVERY Company have?
The EVERY Company is in the 101-250 employee band.
How does The EVERY Company's funding compare to other Biotechnology startups?
The EVERY Company's latest round of $55.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's The EVERY Company Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for The EVERY Company is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.